PHARMACODYNAMIC INTERACTION BETWEEN MIDAZOLAM AND A SPECIFIC BENZODIAZEPINE ANTAGONIST IN HUMANS

被引:57
作者
KLOTZ, U
ZIEGLER, G
LUDWIG, L
REIMANN, IW
机构
关键词
D O I
10.1002/j.1552-4604.1985.tb02866.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:400 / 406
页数:7
相关论文
共 23 条
[1]   MIDAZOLAM KINETICS [J].
ALLONEN, H ;
ZIEGLER, G ;
KLOTZ, U .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (05) :653-661
[2]  
ARVIDSSON SB, 1982, LANCET, V2, P1467
[3]   PHYSOSTIGMINE REVERSAL OF DIAZEPAM-INDUCED HYPNOSIS - STUDY IN HUMAN VOLUNTEERS [J].
AVANT, GR ;
SPEEG, KV ;
FREEMON, FR ;
SCHENKER, S ;
BERMAN, ML .
ANNALS OF INTERNAL MEDICINE, 1979, 91 (01) :53-55
[4]  
DARRAGH A, 1981, LANCET, V2, P8
[5]   RO 15-1788 ANTAGONIZES THE CENTRAL EFFECTS OF DIAZEPAM IN MAN WITHOUT ALTERING DIAZEPAM BIOAVAILABILITY [J].
DARRAGH, A ;
LAMBE, R ;
KENNY, M ;
BRICK, I ;
TAAFFE, W ;
OBOYLE, C .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 14 (05) :677-682
[6]   TOLERANCE OF HEALTHY-VOLUNTEERS TO INTRAVENOUS ADMINISTRATION OF THE BENZODIAZEPINE ANTAGONIST RO-15-1788 [J].
DARRAGH, A ;
LAMBE, R ;
KENNY, M ;
BRICK, I .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 24 (04) :569-570
[7]   ABSENCE OF CENTRAL EFFECTS IN MAN OF THE BENZODIAZEPINE ANTAGONIST RO-15-1788 [J].
DARRAGH, A ;
LAMBE, R ;
OBOYLE, C ;
KENNY, M ;
BRICK, I .
PSYCHOPHARMACOLOGY, 1983, 80 (02) :192-195
[8]   MIDAZOLAM - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE [J].
DUNDEE, JW ;
HALLIDAY, NJ ;
HARPER, KW ;
BROGDEN, RN .
DRUGS, 1984, 28 (06) :519-543
[9]  
FINK M, 1976, CLIN PHARMACOL THER, V20, P184
[10]   EFFECT OF THE BENZODIAZEPINE ANTAGONIST RO 15-1788 ON FLUNITRAZEPAM-INDUCED SLEEP CHANGES [J].
GAILLARD, JM ;
BLOIS, R .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 15 (05) :529-536